Ankit Gupta
@agupta
member of general partner staff @ycombinator
加入 November 2015
1.2K 正在关注 21.2K 粉丝
Completely nuts that PBM revenue is comparable to pharma revenue in the status quo.
Pharma companies take on enormous scientific and execution risk to discover and advance medicines. PBMs are unnecessary middlemen that do neither of those things.
显示更多
